» Articles » PMID: 11403723

Individual Differences in Smoking Reward from De-nicotinized Cigarettes

Overview
Specialty Public Health
Date 2001 Jun 14
PMID 11403723
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Most studies of cigarette smoking and smoking cessation have focused on the psychopharmacological effects of nicotine; relatively few have explored the role of sensory aspects of cigarette smoke. Sensory aspects of cigarette smoke play a role in the maintenance of smoking behavior, and may be particularly important for certain smokers. This paper presents the results of a pooled analysis of nine studies conducted in our laboratory, in order to explore the influence of demographic and smoking-related variables on ratings of de-nicotinized as compared to nicotine-containing cigarettes. A major finding of this analysis is that ratings of smoking derived from de-nicotinized, but not nicotine-containing, cigarettes appear to vary with level of tobacco dependence, suggesting that sensory factors may be more important to highly dependent, as compared to less-dependent, smokers. The implications of these findings for smoking cessation treatment and for future research are discussed.

Citing Articles

Individual variations in motives for nicotine self-administration in male rats: evidence in support for a precision psychopharmacology.

Garcia-Rivas V, Fiancette J, Tostain J, de Maio G, Ceau M, Wiart J Transl Psychiatry. 2024; 14(1):85.

PMID: 38336930 PMC: 10858238. DOI: 10.1038/s41398-024-02774-6.


History repeats itself: Role of characterizing flavors on nicotine use and abuse.

Patten T, De Biasi M Neuropharmacology. 2020; 177:108162.

PMID: 32497589 PMC: 7814940. DOI: 10.1016/j.neuropharm.2020.108162.


Cigarette Design Features: Effects on Emission Levels, User Perception, and Behavior.

Talhout R, Richter P, Stepanov I, Watson C, Watson C Tob Regul Sci. 2017; 4(1):592-604.

PMID: 29250577 PMC: 5730088. DOI: 10.18001/TRS.4.1.6.


Defining the place of habit in substance use disorders.

Vandaele Y, Janak P Prog Neuropsychopharmacol Biol Psychiatry. 2017; 87(Pt A):22-32.

PMID: 28663112 PMC: 5748018. DOI: 10.1016/j.pnpbp.2017.06.029.


Metabotropic glutamate receptor 5 as a potential target for smoking cessation.

Chiamulera C, Marzo C, Balfour D Psychopharmacology (Berl). 2016; 234(9-10):1357-1370.

PMID: 27847973 DOI: 10.1007/s00213-016-4487-3.